No macroscopic or microscopic differences were observed, but the immunohistochemical analysis confirmed fascin knockdown in the HSC-3 shRNA FSCN xenograft tumor cells in contrast with high expression levels in the HSC-3 shRNA Control tumors (Supplementary Figure 4). This evidence concerns the gene FSCN1 and neoplasm.